Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis
article
OA: closed
CC0
⤵ 32 in-corpus citations
AI-generated summary
Dienogest treatment of peritoneal fluid cells from women with endometriosis reduced tumor necrosis factor-alpha production and improved human leukocyte antigen-DR underexpression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo determine the immunological effect of dienogest (DNG), an oral anti-endometriosis drug, on peritoneal fluid (PF) macrophages collected from women with endometriosis. Although it has been suggested that DNG has direct effects on endometriotic cells, including decreased cell proliferation and decreased anti-inflammatory cytokine production, the effects of DNG on PF cells are unclear.Study designThe effects of DNG on PF cells from 34 women with endometriosis and 22 women without endometriosis (controls) were investigated. Expression of human leucocyte antigen (HLA)-DR in PF macrophages, obtained from the peritoneal cavity during laparoscopic surgery, was determined by flow cytometry. HLA-DR expression was measured again after PF cells had been cultured for 72 h in a humidified atmosphere at 37 °C in 5% CO₂-95% air with or without DNG. After 72 h of incubation, the concentration of pro-inflammatory tumour necrosis factor (TNF)-α in the media was measured by enzyme-linked immunosorbent assay.ResultsHLA-DR expression was lower in PF macrophages from women with endometriosis compared with controls. However, after DNG treatment, HLA-DR expression in PF macrophages from women with endometriosis was increased to the same level as in controls. The TNF-α concentration in the media was decreased by DNG.ConclusionsDNG can restore the antigen-presenting ability of PF macrophages by increased HLA-DR expression, and may have an anti-inflammatory effect on PF macrophages in women with endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Coordinated but depressed expression of human leukocyte antigen-DR, intercellular adhesion molecule-1, and CD14 on peritoneal macrophages in women with pelvic endometriosis via openalex
- Decreased human leukocyte antigen–DR expression in the lipid raft by peritoneal macrophages from women with endometriosis via openalex
- Dienogest via openalex
- Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system via openalex
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- IL‐1β TNF‐α, and IL‐2 in Peritoneal Fluid and Macrophage‐Conditioned Media of Women With Endometriosis via openalex
- Increased activation of pelvic macrophages in infertile women with mild endometriosis via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
- REVIEW ARTICLE: Immunopathogenesis of Pelvic Endometriosis: Role of Hepatocyte Growth Factor, Macrophages and Ovarian Steroids via openalex
- Revised endometriosis classification: 1996 via openalex
- Role of Cytokines in Progression of Endometriosis via openalex
- Role of TGF- s in normal human endometrium and endometriosis via openalex
- The development of the implantation theory for the origin of peritoneal endometriosis via openalex
- The role of cell-mediated immunity in pathogenesis of endometriosis. via openalex
- W2111295710 via openalex
- W2112615118 via openalex
- W2062619192 via openalex
- W2042923816 via openalex
- W2001963326 via openalex
- W2159228424 via openalex
- W1996123579 via openalex
- W1963960283 via openalex
- W2084959881 via openalex
- W6718081599 via openalex
Cited by (33)
- The Therapeutic Role of Dienogest in Endometriosis-Associated Pain: From Basics to Clinics 2026
- Impact of endometrioma management strategies on ovarian reserve over the follow-up period, a prospective longitudinal study 2025
- Comparison of the Effects of Dienogest and Leuprolide Acetat on Serum Interferon (IFN-Ɣ) Levels in a Mouse Model of Endometriosis (Mus musculus) 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery 2023
- Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Successful treatment of peritoneal inclusion cysts with dienogest: two case reports 2021
- Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis 2021
- Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle 2020
- A progestin isn’t a progestin: dienogest for endometriosis as a blueprint for future research – Review as a contribution for discussion - 2020
- Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 2015
- Dienogest reduces HSD17β1 expression and activity in endometriosis 2015
- Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment 2014
Source provenance
- europepmc
- last seen: 2026-07-30T06:25:42.655704+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:29.016410+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0
· commercial use OK